Perhexiline Therapy in Heart Failure With Preserved Ejection Fraction Syndrome

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
Up to half of all patients with clinical features of heart failure are found to have normal heart pumping function. Recently the investigators have shown that a drug called perhexiline markedly improved exercise capacity and symptoms in patients with heart failure associated with impaired cardiac pump function. In this proposal the investigators will assess whether perhexiline has beneficial effects in patients with heart failure and a normal heart pumping function.
Epistemonikos ID: 88e73c02f3dbd694bf52863b1fc446f530883c1f
First added on: May 05, 2024